There is broad agreement on supply chain and manufacturing teams across the pharmaceutical industry that pharma organizations can only manage the next wave of changes and disruptions through deep investments in digital technologies. With this in mind, we conducted a survey of more than 100 industry leaders and discovered new details about what pharma leaders are doing to digitally transform. We also learned what these leaders want to accomplish as digital technologies continue to change the way they drive their businesses.
Whether it’s because they want to optimize costs, adapt to the new paradigms of personalized medicine or reduce the threat of growing disruptions, nearly every leader said digital investments are a top priority. Based on the results of our survey, this infographic details three actions pharma supply chain and manufacturing leaders can pursue now to digitally transform.